Although improvements in technique and equipment for continuous ambulatory peritoneal dialysis (CAPO) have reduced the rate of infectious complications, few changes have been made to the dialysis fluids which are routinely used and are unphysiological in terms of low pH, high osmolality, and excessive glucose concentrations. Although the infused solutions are progressively equilibrated following the dialysate exchange, peritoneal host defense systems are at least temporarily exposed to an unphysiological environment that might compromise peritoneal immune cell function. Thus, in addition to infections caused by exogenous or endogenous bacterial contamination, the dialysis fluids have been discussed as a "third factor" potentially involved in the development of peritonitis episodes during CAPO (1) .
In this context, it has been demonstrated that unused CAPO fluids reduce the viability of different cell populations such as lymphocytes, polymorphonuclear leukocytes (PMN), peritoneal macrophages (PM0), and mesothelial cells. Essential functions of phagocytes, such as their capacity to ingest and kill microorganisms, are also inhibited by dialysis fluids, thus reflecting a bioincompatibility of the commonly used solutions.
In this paper we summarize the investigations of the effect of CAPO fluids on the diverse cell functions, including our own in vitro studies on cytokine production.
Effect of CAPO solutions on peritoneal mesothelialcells
Several authors (2) (3) (4) have shown that CAPO induces alterations of the peritoneal membrane. The number of mesothelial cell microvilli is substantially reduced, or microvilli are even completely absent. The intercellular spaces are widened and mesothelial cells may become detached from the basement membrane. These alterations are not attributed to peritoni-tis because they are regularly observed in its absence.
In vitro studies of cultured human mesothelial cells have clearly demonstrated that unused dialysis fluids are cytotoxic to mesothelial cells (5-7), but that longer dwell effluent no longer reduced their viability. The primary reason for this cytotoxic effect appears to be the low pH of unused dialysis fluids (6, 7). Although the cytotoxic potential of CAPO fluids towards mesothelial cells is lost following intraperitoneal equilibration, it may be assumed that repeated infusion of unused CAPO solutions contributes to substantial morphologic and functional alterations of the peritoneal mesothelial membrane (8) .
Effect of CAPO solutions on leukocyte viability
The effect of CAPO fluids on leukocyte viability has been evaluated in vitro in many different populations. Whilst cell death is an important parameter for assessing the effects of dialysis fluids on leukocytes, most of the indirect measurements of cell death have significant drawbacks. In most cases the trypan blue exclusion test has been used to assess cytotoxicity. More recently we have employed the lactate dehydrogenase (LOH) method to measure "cell cytotoxicity" and found a much reduced (compared to trypan blue exclusion data) cytotoxic effect on PMN exposed to unused CAPO fluids for 30 mins (7). These data appear to be more in keeping with the degree of functional inhibition observed in this cell type following dialysate exposure.
As a routine source of peritoneal cells the effluents of stable as well as infected CAPO patients have been used since most studies revealed that these cells remain essentially viable provided there is adequate equilibration of the instilled dialysis fluids: Topley et al. (9) (10) . Polymorphonuclear leukocytes harvested during peritonitis episodes showed> 95% viability following 4 hours i.p. dwell time (9, 11) .
Numerous other investigators have studied the effect of unused CAPO fluids on leukocyte viability: Rubin et al. (12) showed that unused 4.25% glucose solutions reduced the viability of healthy peripheral lymphocytes to as low as 1%, whereas > 95% lymphocytes incubated in control buffer remained viable. Alobaidi et al. (13) demonstrated that the viability of healthy peripheral PMN and also of peritoneal macrophages was greatly reduced following incubation in unused 1.36% Oianeal solutions. Gallimore et al. (14) incubated resident peritoneal macrophages from uremic mice in CAPO fluids containing 4.25% glucose at the original low pH (5.2) as well as following pH adjustment to pH 7.1 and showed that the cell viability increased from 22 at low pH to 77% at neutral pH. Similarly, using healthy peripheral blood mononuclear leukocytes, Jorres et al. (15) demonstrated that conventional CAPO fluids containing 1.5% or 4.25% glucose reduced cell viability only at low pH and that normalising the pH abolished the cytotoxic effect. Thus the bulk of data suggests that CAPO fluids are at least to some extent toxic to different leukocyte populations, largely because of their low initial pH rather than to their hyperosmolality. In vivo dialysates appear to have no adverse effect on leukocyte viability, presumably because equilibration has taken place during the dialysis.
Effect of CAPO solutions on phagocytosis and bactericidal activity of leukocytes
Several authors have also examined the ability of different cells to ingest and kill microorganisms. McGregor et al. (16) described that peritoneal cells obtained from the overnight effluent of stable CAPO patients ingested opsonised staph. epidermidis as effectively as peritoneal cells harvested from a control group, however, intracellular killing of staphylococci was significantly better in the control cells.
Similarly, Alobaidi et al. (13) reported that peritoneal macrophages harvested following 8-18 hours i.p. dwell time showed a normal uptake of unopsonised zymosan particles. In macrophages harvested following shorter dwell periods, however, phagocytic activity 80 was markedly reduced. Peterson et al. (17) likewise showed that the intracellular survival of Candida albicans in peritoneal macrophages from uninfected CAPO patients was significantly enhanced when compared to that of peripheral PMN obtained from healthy donors. A concomitant depressed luminol-enhanced chemoluminescent response and decreased myeloperoxidase levels also indicated a reduced capacity to produce O 2 radicals and hypochlorite, suggesting reduced intracellular killing of ingested microorganisms.
Verbrugh et al. (18) tested the capacity of peritoneal macrophages from the overnight dwell CAPO effluent to phagocytize and kill different strains of staphylococci and found it to be comparable to healthy peripheral polymorphonuclear leukocytes. The same authors also investigated bacterial growth of staphylococci and Escherichia coli in the presence of peritoneal macrophages or peripheral PMN and CAPO effluents (19) . When at least 10 6/ml peritoneal macrophages or PMN were present, bacterial growth was effectively prevented and the number of microorganisms reduced.
Other studies of the effect of unused CAPO fluids on phagocytosis and bacterial killing have attempted to define the mechanism of the inhibitory activity. In a model of peripheral leukocytes phagocytosis of 51Cr-labeled sheep erythrocytes and killing of opsonized E. coli, Ouwe et al. (20) demonstrated that low pH and high osmolality of the dialysis fluids suppressed both phagocyte functions.
The cellular mechanisms of bacterial killing by peritoneal phagocytes were investigated in more detail by Topley et al. (9) who studied the in vitro oxygen uptake and the chemoluminescent response of peritoneal macro phages and PMN stimulated with serum treated zymosan or staph. epidermidis. Incubation of the cells in early dwell CAPO effluents (up to 60 min) markedly decreased the peak chemoluminescent response, which was not the case in 8-hour dwell effluents. Likewise, exposure of both cell populations to fresh dialysis fluid for 30 min at 37°C significantly blocked oxygen radical production. Further experimentation revealed that this inhibition was due to a combined effect of low pH and high concentrations of sodium lactate present in conventional CAPO fluids. A suppression of respiratory burst activation was also reported by lng et al. (21) to occur in neutrophils exposed to unused CAPO fluids.
In summary, fresh CAPO fluids appear to interfere with ingestion and killing of microorganisms by different leukocyte populations. In addition to the well described pH/lactate effects on cell function exposure of leukocytes to hypertonic solutions results in an osmolality mediated suppression of cell function that is not related to the increased glucose concentration per se but appears to have a stimulus-dependent inhibitory effect. A few studies additionally revealed some inhibitory properties of spent dialysates and/or impaired phagocytic functions of cells obtained from CAPO patients.
Effect of CAPO solutions on cytokine production of leukocytes
Several families of inflammatory mediators are known important components of the peritoneal host defense mechanism. Among these, the leukotrienes, lipoxygenase metabolites of the arachidonic acid cascade, all are of interest in CAPO (22) : leukotriene B 4 (LTB 4) induces chemokinesis, chemotaxis, and degranulation of neutrophils and may be important in the recruitment of phaqocytes.in peritoneal inflarnmation. The sulfidopeptide leukotrienes LT~,LT0 4, and LTE 4 promote vascular and airway smooth muscle contraction as well as enhancing vascular permeability (23, 24) .
Of similar importance in the context of CAPO are the lympho-monokines, tumor necrosis factor alpha (TN Fa) and interleukin-6 (IL-6). TNFa, a polypeptide mediator mainly produced by activated monocytes/ macrophages, induces pyrogenic effects, participates in the acute phase response, and augments the inflammatory responses in leukocytes (25, 26) . Furthermore, TNFa activates prostaglandin and collagenase production in fibroblasts (27) and might be important in the development of sclerosing peritonitis. IL-6 is not only produced by activated monocytes, but also by T-cells, fibroblasts, epithelial and endothelial cells. It induces B-cell differentiation and immunoglobulin production as well as the stimulating acute phase protein synthesis in the liver (28) . It also appears to play an important role in peritoneal host defense against bacteria, as suggested by the recent finding that huge amounts of IL-6 are secreted intraperito-neally during CAPO-peritonitis (29) . In this context we recently showed that human peritoneal mesothelial cells produce IL-6 in response to stimulation with IL-1, TNFa, and peritoneal macrophage conditioned medium (30) .
We therefore studied the effect of CAPO solutions on the production of these cytokines from healthy peripheral leukocytes and from peritoneal cells in patients with CAPO peritonitis following stimulation with E. coli lipopolysaccharide (LPS) and calcium ionophore A23187 (11, 15, 31) . lonophore-triggered leukotriene release from cells exposed to control solutions was much greater in inflammatory peritoneal PMN than in healthy peripheral PMN. This suggests that peritoneal PMN during episodes of CAPO peritonitis are primed in vivo for enhanced release of leukotrienes in vitro. Incubation in unused peritoneal dialysis solutions severely depressed leukotriene release from both cell populations. Accordingly, peritoneal PMN stimulated in the presence of dialysates and labeled precursor, i.e. 14C_ arachidonic acid, were unable to produce significar.t amounts of lipoxygenase metabolites as visualized by reverse-phase high performance liquid chromatography and radioactivity monitoring.
We also found a suppressive effect of conventional dialysis solutions on TNFa and IL-6. Control mononuclear leukocytes challenged with E. coli lipopolysaccharide released considerable amounts of these monokines, unlike monocytes exposed to CAPO dialysate containing 4.25% or 1.5% glucose (32) . Low pH as well as high osmolality were important determinants of the inhibitory capacity of the CAPO solutions. Moreover, an inhibitory effect could also be attributed to high glucose levels, since experimental solutions which only differed in their glucose concentrations (1.5% versus 4.25%), but not in their osmolality (300 mas/kg in all solutions) differed markedly in their capacity to interfere with cytokine production. In a series of incubations during which increasing amounts of sodium lactate (0-35 mmol/L) were added to cell culture medium at different pH (7.40-5.50), lactate exerted an additive effect only at low pH, whereas at neutral pH even high amounts of lactate were tolerated. These findings were in keeping with an earlier report of Topley et al. (9) regarding the lactate effects on the respiratory burst activation of phagocytes.
Biacampatibility ot CAPO fluids
Finally, we could show that the inhibitory properties of CAPO solutions were not restricted to unused solutions: when mononuclear leukocytes were stimulated in the presence of CAPO effluent following different i.p. dwell times, a significant inhibition of TNFa production was noted. Interestingly, the inhibition increased with a longer dwell time suggesting that inhibitory substances appear in the peritoneal effluent in increasing amounts in the course of the CAPO cycle (33) .
SUMMARY
The various studies cited here clearly demonstrate that peritoneal dialysis solutions reduce the viability of leukocytes and mesothelial cells, and compromise their capacity for phagocytosis, bacterial killing, and production of cytokines. The inhibitory capacity of the CAPO fluids appears to be related to their low pH, high osmolality, and high glucose concentrations. In some of the experimental settings, lactate was also identified as suppressive factor, but only at low pH.
In clinical CAPO, the pH is rapidly buffered following the dialysate instillation, and the high glucose concentrations and osmolality are also partially equilibrated. Nevertheless, for a certain period of time following the dialysate exchange, peritoneal host defense systems are exposed to an unphysiological environment known to compromise important immune cell functions. Moreover, certain leukocyte properties, such as the production of cytokines, are impaired even following longer i.p. dwell periods. Thus conventional CAPO solutions induce an at least transitory impairment of peritoneal host defense, reflecting a bioincompatibility of the commercial CAPO fluids and underscoring the need for developing fluids with a more physiological formulation. 
